首页 | 本学科首页   官方微博 | 高级检索  
检索        

丁丙诺啡,纳洛酮注射液超快速脱毒的临床研究
引用本文:王文甫,邬志美,刘国阳,肖杰屏.丁丙诺啡,纳洛酮注射液超快速脱毒的临床研究[J].医学临床研究,2009,26(2):292-293.
作者姓名:王文甫  邬志美  刘国阳  肖杰屏
作者单位:湖南省第二人民医院·湖南省自愿戒毒中心,湖南,长沙,410007
摘    要:目的]探讨丁丙诺啡减轻纳洛酮(NLT)冲击疗法的戒断症状与不良反应的作用。方法]海洛因依赖者60例按纳洛酮冲击疗法程序进行快速脱毒,在纳洛酮液体内加用丁丙诺啡者为A组,不用丁丙诺啡者为B组,各30例。两组在冲击治疗期间及次日均静脉输氧一次。每天进行戒断症状与不良反应的观察与评定。治疗后次日全部进行纳曲酮长效缓释剂包理术。结果]A组患者在纳洛酮冲击治疗期间反应轻微,明显优于B组,生命体征多在正常范围内,且A组患者冲击治疗后戒断症状与不良反应明显低于B组(P〈0.01)。两组患者入院至冲击治疗时间平均2.4d,平均住院时间无显著性差异。结论]丁丙诺啡可减轻NLX冲击治疗戒断症状与不良反应,安全性高,很有临床实用价值。

关 键 词:海洛因依赖/药物疗法  丙诺啡/投药和剂量  纳洛酮/投药和剂量

Clinical Efficacy of Buprenorphine OR Reduction of Withdrawal Symptoms and Side Effects of Rapid and High Dose Naloxone Therapy
Institution:WANG Wen- fu , WU Zhi-mei , LIU Guo-yang ,et al( the Voluntary Detoxification Center, Hunan Provincial Brain Hospital ,Changsha 410007, China)
Abstract:Objective]To explore the effect of buprenorphine on reduction of withdrawal symptoms and side effects of rapid and high dose naloxone(NLX) therapy. Methods]Sixty heroin dependence patients receiving routine rapid and high NLX therapy were divided into two groups. Group A ( n = 30) received NLX liquid combined with buprenorphine, and group B ( n = 30) received only NLX liquid. All cases in the two groups accepted Jingshuyang once a day and the next day. The withdrawal symptoms and side effects were observed and evaluated everyday. All patients accepted embedment of prolonged-action NLX in the next day after therapy. Results]The side effects and withdrawal symptoms were decreased significantly in group A ( P 〈0. 01). The average time span from admission to naloxone treatment was 2.4 days. The average time span from admission to out-hospital between group A and B group cases had no statistical difference. Conclusion] Buprenorphine can reduce withdrawal symptoms and side effects of rapid and high dose NLX. It has important clinical value with more safe.
Keywords:heroin dependence/DT  buprenorphine/AD  naloxone/AD
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号